PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, supplying promising enhancements across a variety of professional medical and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA presents a safer, additional reputable substitute for the